AllSquare Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-170
Closed -$15.3K – 552
2024
Q4
$15.3K Buy
+170
New +$16.5K 0.01% 333
2024
Q2
– Sell
-236
Closed -$22.4K – 544
2024
Q1
$22.4K Hold
236
– – 0.01% 284
2023
Q4
$21.1K Hold
236
– – 0.01% 290
2023
Q3
$17.2K Hold
236
– – 0.01% 311
2023
Q2
$19.6K Sell
236
-130
-36% -$10.9K 0.01% 301
2023
Q1
$27.9K Hold
366
– – 0.02% 274
2022
Q4
$30.4K Hold
366
– – 0.02% 250
2022
Q3
$29K Hold
366
– – 0.02% 247
2022
Q2
$27K Hold
366
– – 0.02% 264
2022
Q1
$33K Hold
366
– – 0.02% 263
2021
Q4
$41K Hold
366
– – 0.02% 244
2021
Q3
$46K Hold
366
– – 0.03% 232
2021
Q2
$50K Hold
366
– – 0.03% 236
2021
Q1
$50K Hold
366
– – 0.03% 230
2020
Q4
$52K Buy
366
+28
+8% +$3.59K 0.03% 195
2020
Q3
$38K Buy
338
+45
+15% +$5.04K 0.03% 227
2020
Q2
$33K Hold
293
– – 0.02% 221
2020
Q1
$23K Buy
293
+163
+125% +$14.4K 0.02% 238
2019
Q4
$12K Hold
130
– – 0.01% 314
2019
Q3
$10K Buy
+130
New +$10.8K 0.01% 326

Other funds holding XBI

AllSquare Wealth Management's XBI Position: Q1 2025 in Review

AllSquare Wealth Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 170 shares — an estimated $15.3K sold.

AllSquare Wealth Management first reported a position in XBI in Q3 2019 and held it in 20 quarters. The position peaked at $52K in Q4 2020. 685 funds tracked by Wall St. Rank hold XBI as of Q1 2025.

  • AllSquare Wealth Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
  • AllSquare Wealth Management sold 170 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $15.3K.
  • AllSquare Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2019 and held it in 20 quarters.
  • AllSquare Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $52K in Q4 2020.
  • 685 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.

Based on AllSquare Wealth Management's 13F filing for Q1 2025, filed 6 May 2025.